A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI

Clinical trial NCT06533358 · UNKNOWN

Trial details

NCT number: NCT06533358
Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2024-02-27
Primary completion: 2024-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.